Physician profile
Michael Mancano
NPI 1649912692
$4,614.47
in general payments reported to CMS, 2019-2025
16 companies · $1,915 in 2025
The $1,915 reported for 2025 was more than what 83% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $664 · 2024: $2,035 · 2025: $1,915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,691 · Travel and Lodging: $1,923.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,691.01 |
| Travel and Lodging | $1,923.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $2,573.71 | 2023-2025 | Truelok, Physio-Stim |
| Integra Lifesciences Corporation | $342.06 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Treace Medical Concepts, INC. | $298.41 | 2023-2025 | |
| Stryker Corporation | $205.75 | 2024-2025 | 7 X 23mm Citrelock Implant, Allofiber, Allopure |
| Abbott Laboratories | $170.27 | 2024 | Proclaim |
| Medline Industries LP | $166.05 | 2025 | |
| Linvatec Corporation | $141.54 | 2024 | Colink 2, Biobrace 23mm |
| Coastal Medical Technologies LLC | $141.41 | 2025 | |
| Paratek Pharmaceuticals, INC. | $121.80 | 2024 | Nuzyra |
| Abbvie INC. | $121.71 | 2023 | |
| Smith+Nephew, INC. | $113.45 | 2025 | Bone Anchors With Arthroscopic Delivery System |
| Bone Support INC. | $98.14 | 2024 | Cerament G, Ceramentbone Void Filler |
| Melinta Therapeutics, LLC | $46.02 | 2024 | Orbactiv, Kimyrsa |
| Solventum Corporation | $31.93 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Organogenesis INC. | $27.11 | 2025 | Affinity |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgenex LLC | $15.11 | 2025 | Renograft, Pellograft, Surmatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mancano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.